NL7007521A - - Google Patents

Info

Publication number
NL7007521A
NL7007521A NL7007521A NL7007521A NL7007521A NL 7007521 A NL7007521 A NL 7007521A NL 7007521 A NL7007521 A NL 7007521A NL 7007521 A NL7007521 A NL 7007521A NL 7007521 A NL7007521 A NL 7007521A
Authority
NL
Netherlands
Application number
NL7007521A
Other versions
NL148241B (nl
Inventor
N Ishida
M Kikuchi
Original Assignee
N Ishida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N Ishida filed Critical N Ishida
Publication of NL7007521A publication Critical patent/NL7007521A/xx
Publication of NL148241B publication Critical patent/NL148241B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/803Physical recovery methods, e.g. chromatography, grinding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NL707007521A 1969-05-26 1970-05-25 Werkwijze voor het bereiden van een therapeutisch preparaat met anti-virale werking door vereniging van een uit mycophyta verkregen dubbelstrengig ribonucleinezuur met een voor therapeutische doeleinden geschikte drager, alsmede gevormd therapeutisch preparaat. NL148241B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4040469 1969-05-26

Publications (2)

Publication Number Publication Date
NL7007521A true NL7007521A (https=) 1970-11-30
NL148241B NL148241B (nl) 1976-01-15

Family

ID=12579713

Family Applications (1)

Application Number Title Priority Date Filing Date
NL707007521A NL148241B (nl) 1969-05-26 1970-05-25 Werkwijze voor het bereiden van een therapeutisch preparaat met anti-virale werking door vereniging van een uit mycophyta verkregen dubbelstrengig ribonucleinezuur met een voor therapeutische doeleinden geschikte drager, alsmede gevormd therapeutisch preparaat.

Country Status (9)

Country Link
US (1) US3907778A (https=)
BE (1) BE750918A (https=)
CA (1) CA932284A (https=)
DE (1) DE2025810C3 (https=)
FR (1) FR2051558B1 (https=)
GB (1) GB1303506A (https=)
NL (1) NL148241B (https=)
SE (1) SE376170B (https=)
ZA (1) ZA703501B (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157637A (en) * 1963-05-21 1964-11-17 Joseph X Khym Method of separating nucleotides
US3444041A (en) * 1965-09-29 1969-05-13 Univ Illinois In vitro synthesis of ribonucleic acids and enzyme therefor
US3389133A (en) * 1966-08-10 1968-06-18 Schwarz Biores Inc Process for isolating and purifying soluble ribonucleic acid

Also Published As

Publication number Publication date
SE376170B (https=) 1975-05-12
FR2051558A1 (https=) 1971-04-09
BE750918A (fr) 1970-11-03
FR2051558B1 (https=) 1974-06-14
DE2025810A1 (de) 1970-12-17
US3907778A (en) 1975-09-23
GB1303506A (https=) 1973-01-17
NL148241B (nl) 1976-01-15
DE2025810B2 (de) 1980-06-26
DE2025810C3 (de) 1981-03-19
CA932284A (en) 1973-08-21
ZA703501B (en) 1971-01-27

Similar Documents

Publication Publication Date Title
AU465452B2 (https=)
AU429630B2 (https=)
AU450150B2 (https=)
AU442375B2 (https=)
AU2355770A (https=)
AU470301B1 (https=)
AU5113869A (https=)
AU442554B2 (https=)
AU428129B2 (https=)
AU428074B2 (https=)
AU470661B1 (https=)
AU438128B2 (https=)
AU442285B2 (https=)
AU410358B2 (https=)
AU442322B2 (https=)
AU442357B2 (https=)
AU414607B2 (https=)
AU442463B2 (https=)
AU442535B2 (https=)
AU442538B2 (https=)
AU417208B2 (https=)
AU5228269A (https=)
CS148391B1 (https=)
AU5598769A (https=)
AU4949169A (https=)

Legal Events

Date Code Title Description
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: NAKAO

V4 Discontinued because of reaching the maximum lifetime of a patent